Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04506684 · ClinicalTrials.gov registry record
Reveal LINQ Respiration Clinical Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 79
- Enrollment target
NCT04506684 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 79 participants.
The verdict
NCT04506684 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The LINQ™ Respiration study will collect and characterize Reveal LINQ™ derived respiration data from patients undergoing a simulated 24-hour time period while being monitored with capnography.
Interventions
- DEVICE Investigational RAMware downloaded onto Reveal LINQ device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04506684
The ClinicalTrials.gov registry entry for NCT04506684 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational RAMware downloaded onto Reveal LINQ device is the first listed.
NCT04506684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04506684 about?
NCT04506684 is a clinical study titled "Reveal LINQ Respiration Clinical Study". The LINQ™ Respiration study will collect and characterize Reveal LINQ™ derived respiration data from patients undergoing a simulated 24-hour time period while being monitored with capnography.
What is the current status of trial NCT04506684?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2020-09-25. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04506684?
The interventions under investigation include: Investigational RAMware downloaded onto Reveal LINQ device (DEVICE).
Who is sponsoring clinical trial NCT04506684?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.